expect steadili rise compani deliv better-than-
expect result experienc encourag acceler sever busi unit
like fuel posit investor sentiment also propos optimist
outlook expect although top line growth still like
view conserv
broad-bas strength drive top line
face easier sequenti comp quarter deliv strong perform
support robust contribut across geographi new product launch
outperform multipl busi unit revenu knee vs hip
vs spine cmf vs dental vs
exceed street estim set vs saw modest under-perform
knee franchis particularli impress world-wide growth driven
persona recent launch revis system rosa knee growth also acceler
respons global knee growth forecast continu
acceler rosa system placement plan increas commerci
effort includ capit sale forc expans enhanc surgeon train
initi remain encourag earli rosa knee launch dynam
deliv om target
gm exceed street expect although om
lighter expect primarili due higher sg expens importantli still
abl achiev om target full year think om result
avoid scrutini investor appreci zbh plan sacrific slight margin expans
invest cost associ key product launch like rosa ep
street estim softer margin perform off-set
lower interest/oth expens addit lower-than-expect tax rate
issu top line guidanc slightli ahead rang
anticip manag histor state goal growth
strong result like driver behind bolster guidanc expect
investor still view newli issu rang somewhat conserv
ep rang bracket consensu estim note
experi benefit addit sell day first quarter expect
provid benefit bp growth remain quarter
number sell day experi impact
restructur paint promis pictur futur margin profil
also provid detail newli implement multi-year restructur plan
seek cut cost drive favor mix invest higher growth revenu
opportun success compani expect program contribut
annual adjust pre-tax opex save furthermor believ
enabl compani reach oper margin least end
view time action expect investor gradual place
emphasi compani margin profil top line revenu stabil
begin acceler sub rang seen previou year
pleas see page report import disclosur
market perform rate stem zbh outsiz exposur reconstruct joint
market make compani heavili reliant hip knee implant year
weak recon market cap sale growth biomet merger continu
roll-out persona knee system better-posit captur market share
strengthen recon busi howev recent suppli issu delay zbh return
market growth rate remedi suppli constraint demonstr sustain
improv recon well compani non-recon area key
full launch rosa knee
updat launch time rosa spine
hip
elimin exist suppli constraint
resolut suppli constraint line
manag guidanc
faster-than-expect resolut
continu success integr
continu stabil global
merger acquisit synergi
anticip
deterior global recon market
market share loss knee hip
design sell reconstruct spinal trauma devic compani also
biolog sport medicin dental bone heal microfix relat surgic devic
product portfolio manag oper three geograph segment
america consist unit state includ north central
south american market europ consist europ includ middl east
africa market asia pacif compris japan australia select market
zimmer merg biomet june greatli expand orthoped scale
rosa continu garner strong demand
although shi away provid specif number around rosa capit sale
manag remain enthus demand momentum continu
build commerci infrastructur support system includ
hire addit capit sale rep also focu attent surgeon
train drive adopt quarter sinc initi launch
cite procedur complet rosa far mani
surgeon provid posit feedback capabl platform promis
earli respons bode well rosa potenti contribut knee
franchis state rosa contribut less half overal growth
quarter knee busi new product knee fuel major
growth quarter rosa credit contribut
half overal knee growth roll-out progress anticip even stronger
contribut rosa come quarter posit outlook continu
success rosa launch also driven strong overal orthoped robot capit
increas price due improv top-lin trajectori
rais price target per share account increas
optim top-lin acceler potenti well recent expans
median multipl large-cap med tech compani valuat analysi consist
earn ebitda price-to-earnings multipl repres
turn discount peer group median view discount multipl assign
appropri given lower top-lin growth profil look visibl
revenu growth driver acceler organ revenu growth north
convict multi-year margin expans trajectori appropri
encourag manag continuedexecut would remain sidelin
market perform rate
compani report thomson eikon cowen compani
actualcowen growth growth growth growth growth growth growth per count select revenu metric incom statement mm except ep cowen
compani report thomson eikon cowen compani
mm except oper biomet oper cowen
compani report cowen compani
mm except ex-fx ex-fx ex-fx ex-fx ex-fx ex-fx ex-fx ex-fx ex-fx spine ex-fx ex-fx ex-fx ex-fx revenu less growth impact ex-fx growth day day impact report ex-fx ex-fx ex sell day cowen
valuat methodolog primarili base current year forward year ev/sal
ev/ebitda multipl well current year forward price-to-earnings multipl total return/p
ratio market cap/fre cash flow metric dividend yield comp
orthoped industri risk continu util pressur account
organ play bigger role health care deliveri competit dynam global
potenti regulatori delay reject failur devic clinic trial econom
sensit price pressur and/or weaken consum demand develop market
econom and/or polit uncertainti emerg market intellectu properti
deeper util pressur recon busi us europ worsen
competit dynam global potenti regulatori delay reject failur
devic clinic trial econom sensit price pressur and/or weaken
demand develop market econom and/or polit uncertainti emerg
market fluctuat foreign exchang rate
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock corp secur
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
